|
|
Volumn 12, Issue 6, 1999, Pages 402-403
|
|
On the role of MRS in drug development [1]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CAPECITABINE;
CARBOPLATIN;
FLUOROURACIL;
IFOSFAMIDE;
IPROPLATIN;
OGT 719;
TEMOZOLOMIDE;
UNCLASSIFIED DRUG;
APOPTOSIS;
AREA UNDER THE CURVE;
DOSE RESPONSE;
DRUG DETERMINATION;
DRUG DISTRIBUTION;
DRUG ELIMINATION;
DRUG UPTAKE;
GAS CHROMATOGRAPHY;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
LETTER;
NUCLEAR MAGNETIC RESONANCE IMAGING;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
SIGNAL NOISE RATIO;
SOLID TUMOR;
TUMOR BIOPSY;
ANIMALS;
DRUG DESIGN;
HUMANS;
MAGNETIC RESONANCE SPECTROSCOPY;
PHARMACOKINETICS;
|
|
EID: 0032826593
PISSN: 09523480
EISSN: None
Source Type: Journal
DOI: 10.1002/(SICI)1099-1492(199910)12:6<402::AID-NBM604>3.0.CO;2-F Document Type: Letter |
|
Times cited : (4)
|
|
References (23)
|
